Limno was selected to participate in the program “Misión Directa a Boston”, a program funded by Extenda- Agencia Andaluza de Promoción Exterior, from the Andalusian Government to promote the internalization of Andalusian start-up companies. Boston is one of the more important innovation hubs in the field of Biotechnology, hosting prestigious universities and research centers, as well as pharmaceutical and biotech companies and investors groups. During our trip to Boston, Limno’s team had the opportunity to meet with pharmaceutical industries, such as Boehringer Ingelheim and Novartis, and companies specialized in the development of clinical trials. We also presented our project to venture capital groups such as UPMC.
- Limnopharma awarded with a Research Project from the NEOTEC program (CDTI; Spanish Ministry of Science and Innovation)
- Limnopharma signs a research agreement with “Fundación Progreso y Salud” for the execution of the “Lead Retina” research project
- New SAB members
- Limnopharma’s new CEO
- Limno participates in “Misión Directa a Boston